Celgene invests in Triphase drug, may buy in $1 bln-plus deal longmia@halifax.ca - 29 January 2019 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
